Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2010 | 07-2009 | 07-2008 | 07-2007 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 429 | 286 | 270 | 446 |
| Accounts receivable | -312 | -704 | 553 | -24 |
| Other Working Capital | 540 | -718 | -20 | -221 |
| Other Operating Activity | -12,850 | -12,021 | -7,800 | -6,280 |
| Operating Cash Flow | $-12,193 | $-13,157 | $-6,997 | $-6,079 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -607 | -932 | -266 | -63 |
| Sale Of Investment | 48 | N/A | 0 | 6,640 |
| Investing Cash Flow | $-559 | $-932 | $-266 | $6,577 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 11,947 | 9,659 | 14,614 | 6,480 |
| Financing Cash Flow | $11,947 | $9,659 | $14,614 | $6,480 |
| Exchange Rate Effect | -564 | -133 | 327 | 9 |
| Beginning Cash Position | 14,494 | 19,057 | 11,379 | 4,392 |
| End Cash Position | 13,125 | 14,494 | 19,057 | 11,379 |
| Net Cash Flow | $-805 | $-4,430 | $7,351 | $6,978 |
| Free Cash Flow | ||||
| Operating Cash Flow | -12,193 | -13,157 | -6,997 | -6,079 |
| Capital Expenditure | -607 | -932 | -266 | -63 |
| Free Cash Flow | -12,800 | -14,089 | -7,263 | -6,142 |